TransCanna via Lyfted Farms Wins Unanimous Recommendation for County Approval of Daly Facility Use Permit

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce last evening (December 19, 2019) that Lyfted Farms, Inc. ("Lyfted or Lyfted Farms") a wholly owned subsidiary of TransCanna received unanimous recommendation from the Stanislaus County Planning Commission to recommend to the Board of Supervisors the approval of the Daly Project.

TransCanna Wins 1st and 3rd place at the 2019 Emerald Cup for SolDaze CBD Edibles

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that SolDaze Snacks won first place for their tropical mango fruit bites and third place for their strawberry mango fruit bites in the CBD edible category at the 2019 Emerald Cup. SolDaze has won multiple times at the Emerald Cup, including in 2018 for its THC edibles.

TransCanna to Maximize Value Proposition with Expansion of Sales, Fulfillment and Distribution Strategy

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has developed a comprehensive strategy for a four phase expansion of sales and fulfillment in the Northern and Southern California markets for all TransCanna brands.

Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals

Highlights - Formulation makes water soluble cannabidiol (CBD) oil up to 40 times better absorbed - Taste masking technology increases acceptance in oral pharma and food formulations - Project Leader is Dr Roscoe Moore Jr - retired United States Assistant Surgeon General - an advocate of evidenced based CBD - Technology could apply to most fat-soluble medications and foods, including curcumin and Vitamin D - Commercialisation by licensing begins in North America in 2020

iGalen and Holista announce resolution with ATM Metabolics

Holista, a research-driven biotech company that develops natural ingredient and wellness products, and its distributor iGalen are pleased to announce that they have resolved their disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.

RETRANSMISSION: TransCanna and Lyfted Farms Sign Definitive Purchase Agreement

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has executed a definitive agreement (the "SPA") for the purchase of all of the outstanding common shares of Lyfted Farms, Inc. ("Lyfted"), a state licensed, vertical cannabis company located in the Central Valley, California.

Improve your Overall Health with the help of Acupuncture Therapy, visit Jessica Maguire

Having carved a niche of excellence in the area of physiotherapy, Jessica Maguire has gained extensive exposure in the field. Whether you are having trouble sleeping or you are suffering from muscle inflammation, acupuncture can help you in solving various discomforts that you might be facing.

TransCanna Announces Signing of Definitive Agreement with SolDaze

TransCanna Holdings Inc. (CSE: TCAN)(FSE: TH8)("TransCanna" or the "Company") is pleased to announce that it has executed a definitive purchase agreement (the "SPA") for all of the outstanding equity interest in Tres Ojos Naturals LLC, doing business as SolDaze, a limited liability company based in Santa Cruz, California.

MIT's research enterprise in Singapore launches new research group, boosting nation's cell therapies R&D

MIT's Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore's National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies. -- S$10 million a year to be invested in SMART CAMP in a multi-year effort -- New interdisciplinary research group, SMART CAMP, will bring together 35 MIT and Singapore investigators -- Complementary and integrated programme with Singapore's Agency for Science Technology and Research (A*STAR) cell manufacturing effort, supported by the National Research Foundation (NRF) -- SMART CAMP deploys MIT's innovation methodologies in Singapore's thriving biopharmaceutical industry, tapping market potential of billions a year.

TransCanna Terminates Transaction with Lifestyle Delivery Systems Inc.

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") and Lifestyle Delivery Systems Inc. (CSE: LDS) (FSE: LD6) (WKN: A14XHT) (OTCQX: LDSYF) ("LDS") have mutually agreed to terminate a letter of intent ("LOI") dated June 28, 2019 whereby TransCanna was to acquire LDS. After careful review of the transaction and current market conditions, TransCanna has determined the acquisition of LDS by TransCanna under the terms of the LOI would not be in the best interests of shareholders, and as a result, the LOI has been terminated by both parties.

Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

ovotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing

Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight (8) hours.